Projects funded by the NCN
Anaplastic Lymphoma Kinase (ALK) Overexpression as a Prognostic and Predictive Factor in Serous Ovarian Carcinoma
2017/25/N/NZ4/00558
Keywords:
Serous ovarian carcinoma Anaplastic lymphoma kinase ALK Immunohistochemistry Fluorescent in situ hybridization FISH Predictive factors Prognostic factors
Descriptors:
- NZ4_5: Anatomical pathology
- NZ1_1: Molecular biology
Panel:
NZ4 - Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology
Host institution :
Gdański Uniwersytet Medyczny, Wydział Lekarski
woj. pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 13 - announced on 2017-03-15
Amount awarded: 120 000 PLN
Project start date (Y-m-d): 2018-03-28
Project end date (Y-m-d): 2022-03-27
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- Prognostic value of ALK overexpression and molecular abnormalities in high-grade serous ovarian carcinomaAuthors:Adam Gorczyński, Kevin Miszewski, Yann Gager, Sonja Koch, Jane Pötschke, Dimitar Ugrinovski, Jörg Gabert, Agata Pospieszyńska, Dariusz Wydra, Renata Duchnowska, Bartosz Szymanowski, Szczepan Cierniak, Irene Kruecken, Karsten Neumann, Katarina Mirkov, Wojciech Biernat, Piotr CzapiewskiAcademic press:Cancer Biomarkers , Wydawca: IOS PressStatus:Accepted for publicationDOI:10.3233/CBM-230117 - link to the publication